Ruxolitinib: a targeted treatment option for patients with polycythemia vera
Kris Vaddi,1 Srdan Verstovsek,2 Jean-Jacques Kiladjian3 1Drug Discovery, Incyte Corporation, Wilmington, DE, 2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 3Clinical Investigations Center, Hôpital Saint-Louis et Université Paris Did...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-05-01
|
| Series: | Blood and Lymphatic Cancer: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/ruxolitinib-a-targeted-treatment-option-for-patients-with-polycythemia-peer-reviewed-article-BLCTT |